Epsilon M&A Deal Report - Organon BioSciences (OBS)
Transaction Multiples for the Valuation of Private Companies
Schering-Plough / Organon BioSciences (OBS)
No EMAT :
22045
Announced Date :
12/03/2007
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Schering-Plough
Target :
Organon BioSciences (OBS)
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Founded in 1923, Organon BioSciences NV (OBS) develops, manufactures, markets, and sells prescription medicines targeting both human and animal therapeutic uses . > Organon operates two discrete...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/10/2010 | Orpea | Mediter Group and Medibelge Group | Belgium | ** | 22037 |
| 28/10/2010 | Alere Holdings Bermuda Ltd | AdnaGen | Germany | * | 22029 |
Source: Epsilon Research / EMAT
